Acute promyelocytic leukemia (APL): Therapy results and prognostic factors over a 23-year period.

被引：0
|
作者：
Thomas, X [1 ]
Belhabri, A [1 ]
TreilleRitouet, D [1 ]
Fiere, D [1 ]
Archimbaud, E [1 ]
机构：
[1] HOP EDOUARD HERRIOT,SERV HEMATOL,LYON,FRANCE
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：676 / 676
页数：1
相关论文
共 50 条
  • [41] A High Prevalence of Obesity in Acute Promyelocytic Leukemia (APL): Is Obesity a Risk Factor for APL? Implication of Targeted Therapy to Control Obesity and APL Prevention
    Qualtieri, Julianne
    Tedesco, Jason
    Savani, Bipin N.
    Ayers, Gregory
    Kumar, Meera
    Greer, John P.
    Head, David R.
    Reddy, Nishitha
    BLOOD, 2009, 114 (22) : 1205 - 1205
  • [42] PROGNOSTIC FACTORS IN ACUTE PROMYELOCYTIC LEUKEMIA - A RETROSPECTIVE STUDY OF 67 CASES
    THOMAS, X
    ARCHIMBAUD, E
    TREILLERITOUET, D
    FIERE, D
    LEUKEMIA & LYMPHOMA, 1991, 4 (04) : 249 - 256
  • [43] Prognostic Impact of Chromosomal Variation in Patients with Acute Promyelocytic Leukemia (APL); Analysis of 775 Cases Enrolled in the Japan Adult Leukemia Study Group APL Studies
    Adachi, Miwa
    Takeshita, Akihiro
    Taki, Tomohiko
    Ohtake, Shigeki
    Shinagawa, Katsuji
    Kiyoi, Hitoshi
    Matsuda, Mitsuhiro
    Takahashi, Masatomo
    Emi, Nobuhiko
    Kobayashi, Yukio
    Miyamura, Koichi
    Fujita, Hiroyuki
    Sakura, Toru
    Iwanaga, Masako
    Usui, Noriko
    Miyawaki, Shuichi
    Asou, Norio
    Ohnishi, Kazunori
    Miyazaki, Yasushi
    Naoe, Tomoki
    BLOOD, 2014, 124 (21)
  • [44] Comparing the epidemiology, clinical characteristics and prognostic factors of acute myeloid leukemia with and without acute promyelocytic leukemia
    Kamath, Geetanjali R.
    Tremblay, Douglas
    Coltoff, Alexander
    Caro, Jessica
    Lancman, Guido
    Bhalla, Sheena
    Najfeld, Vesna
    Mascarenhas, John
    Taioli, Emanuela
    CARCINOGENESIS, 2019, 40 (05) : 651 - 660
  • [45] URUGUAYAN EXPERIENCE IN UVEAL MELANOMA: RESULTS ON 72 PATIENTS FOLLOWED DURING A 23-YEAR PERIOD
    Krygier, G.
    Martinez, A.
    De Colla, A.
    Blanco, A.
    Priario, J.
    Muse, I. M.
    Sabini, G.
    ANNALS OF ONCOLOGY, 2008, 19 : 242 - 242
  • [46] Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL
    Testi, Anna Maria
    Pession, Andrea
    Diverio, Daniela
    Grimwade, David
    Gibson, Brenda
    de Azevedo, Amilcar Cardoso
    Moran, Lorena
    Leverger, Guy
    Elitzur, Sarah
    Hasle, Henrik
    ten Bosch, Jutte van der Werff
    Smith, Owen
    De Rosa, Marisa
    Piciocchi, Alfonso
    Lo Coco, Francesco
    Foa, Robin
    Locatelli, Franco
    Kaspers, Gertjan J. L.
    BLOOD, 2018, 132 (04) : 405 - 412
  • [47] Preliminary results from the north American acute promyelocytic leukemia (APL) study C9710.
    Powell, Bayard L.
    Moser, Barry
    Stock, Wendy
    Gallagher, Robert E.
    Willman, Cheryl L.
    Stone, Richard M.
    Rowe, Jacob M.
    Coutre, Steven
    Feusner, James H.
    Gregory, John
    Couban, Stephen
    Appelbaum, Frederick R.
    Tallman, Martin S.
    Larson, Richard A.
    BLOOD, 2006, 108 (11) : 171A - 171A
  • [48] ACUTE LYMPHOBLASTIC-LEUKEMIA IN ADULTS - PROGNOSTIC FACTORS AND 10 YEAR TREATMENT RESULTS
    BEZWODA, WR
    SEYMOUR, L
    ARIAD, S
    MACPHAIL, P
    LEUKEMIA & LYMPHOMA, 1991, 5 (5-6) : 347 - 355
  • [49] Factors contributing to mortality in patients with tuberculosis in Wolverhampton over a 10 year period.
    Matonhodze, M
    Mann, JS
    Connellan, SJ
    Catchpole, C
    THORAX, 2000, 55 : A27 - A27
  • [50] Reducing standard postremission chemotherapy in acute promyelocytic leukemia (APL) with risk-adapted therapy.
    Mulford, DA
    Maslak, PG
    Weiss, MA
    Scheinberg, DA
    Jurcic, JG
    BLOOD, 2003, 102 (11) : 619A - 620A
12345